Simplex Trading
INDV icon

Simplex Trading’s Indivior Pharmaceuticals INDV Stock Holding History

Simplex Trading’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$321K Buy
10,533
+448
+4% +$14.8K ﹤0.01% 3752
2025
Q4 		$362K Buy
+10,085
New +$308K ﹤0.01% 3627
2025
Q1 		– Sell
-4,703
Closed -$49.4K – 9017
2024
Q4 		$58K Buy
+4,703
New +$48.4K ﹤0.01% 5723

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Simplex Trading's INDV Position: Q1 2026 in Review

Simplex Trading increased its Indivior Pharmaceuticals (INDV) stake by 4.4% in Q1 2026, buying an estimated $14.8K and bringing the position to 10,533 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #3752.

Simplex Trading first reported a position in INDV in Q4 2024 and has held it in 3 quarters since. The position peaked at $362K in Q4 2025. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Simplex Trading held 10,533 shares of Indivior Pharmaceuticals worth $321K as of Q1 2026.
  • Simplex Trading bought 448 Indivior Pharmaceuticals shares in Q1 2026, an estimated $14.8K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3752 holding.
  • Simplex Trading first reported a position in Indivior Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Simplex Trading's Indivior Pharmaceuticals position peaked at $362K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.